10-Q: FONAR Corporation Reports Q3 2025 Results: Net Income Declines Amid Rising Costs

FONAR Corporation's Q3 2025 results show a decrease in net income despite a slight revenue increase, driven by rising costs and expenses.

Summary

• FONAR Corporation reported a net income of $9.3 million on revenues of $77.1 million for the nine months ended March 31, 2025.
• This compares to a net income of $12.5 million on revenues of $76.9 million for the same period in 2024.
• Operating income decreased to $10.7 million for the nine months ended March 31, 2025, from $15.2 million in the prior year.
• For the three months ended March 31, 2025, net income was $3.1 million on revenues of $27.2 million, compared to $2.5 million on revenues of $25.7 million in 2024.
• The increase in costs and expenses is primarily attributable to additional reserves of $2.5 million and a new outside billing contract.
• The aggregate number of scans performed by the sites owned decreased to 41,643 scans from 42,718 scans.
• The aggregate number of scans performed by the sites managed increased to 119,137 scans from 112,072 scans.
• HMCA revenues decreased slightly to $70.7 million from $71.1 million.
• The company repurchased 115 shares at a cost of $1,806 during the nine months ended March 31, 2025.
• As of March 31, 2025, the remaining balance under the repurchase plan was $2,928.

Sentiment

Score: 5

Explanation: The report presents a mixed picture with slight revenue growth offset by increased costs and decreased profitability. The company faces industry-wide challenges, but is taking steps to improve operations and promote its unique product.

Positives

• Revenues from product sales and service and repair fees increased from $5.9 million to $6.4 million for the first nine months of fiscal 2025.
• The aggregate number of scans performed by the sites managed increased to 119,137 scans from 112,072 scans.
• Working capital increased to $127.1 million at March 31, 2025 from $122.5 million at June 30, 2024.

Negatives

• Net income decreased from $12.5 million to $9.3 million for the nine months ended March 31, 2025.
• Operating income decreased from $15.2 million to $10.7 million for the nine months ended March 31, 2025.
• The company recorded additional reserves of $2.5 million, impacting profitability.
• The aggregate number of scans performed by the sites owned decreased to 41,643 scans from 42,718 scans.
• HMCA revenues decreased slightly to $70.7 million from $71.1 million.

Risks

• Reduced reimbursement rates from Medicare, government programs, and private insurance companies continue to pressure revenue.
• Inflation in material and labor costs limits the ability to control operating expenses.
• Cybersecurity threats pose a risk to operations and could result in significant costs.
• Dependence on referrals from unaffiliated physicians could impact scan volumes.
• Changes in Florida insurance law could negatively impact diagnostic imaging facilities.
• Economic uncertainty and lower reimbursement rates for MRI scans have depressed the market for MRI scanner products.

Future Outlook

The company is committed to improving operating results and dealing with challenges posed by legislative and regulatory requirements, but factors beyond their control make it difficult to forecast future operating results.

Management Comments

• Last quarter, we recorded a significant reserve against accounts receivable which was attributable to American Transit Insurance Company, a New York based motor vehicle insurer who has recently indicated that they are approaching insolvency.
• We are monitoring the situation for new developments.
• Management believes this product improves the quality of the images produced by FONAR equipment, and provides operational efficiencies that result in additional scan volume in the scanners operated by HMCA facilities.
• Management is seeking to promote wider market recognition of FONARs scanner products, and to increase demand for Upright scanning at the facilities HMCA owns or manages.

Industry Context

The report highlights the challenges faced by diagnostic imaging centers due to reduced reimbursement rates and increasing competition, reflecting broader trends in the healthcare industry.

Comparison to Industry Standards

• The report mentions competition from major players like General Electric, Siemens, Hitachi, and Phillips, who have greater financial resources and production capacity.
• The company is focused on its unique Stand-Up (Upright) MRI scanner, which differentiates it from competitors.
• The company is working to improve the quality of the images produced by FONAR equipment, and provides operational efficiencies that result in additional scan volume in the scanners operated by HMCA facilities.

Legal Proceedings

• There were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2024.

Related Party Transactions

• Tallahassee Magnetic Resonance Imaging, Inc., Stand Up MRI of Boca Raton, Inc., and Stand Up MRI & Diagnostic Center, Inc. (all related medical practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual management agreement.
• Bensonhurst MRI Limited Partnership (Bensonhurst), in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110 per annum.
• Radian Healthcare Management, LLC (Radian), which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees at a fee of approximately $150 and $146 for the nine months ended March 31, 2025 and 2024, respectively.
• On December 31, 2023, the Company entered into an agreement with Magnetic Resonance Management, LLC (MRM) for the sale of a MRI scanner.

Stakeholder Impact

• Shareholders: Decreased net income may negatively impact shareholder value.
• Employees: Cost control measures may impact staffing and compensation.
• Customers: Continued investment in technology aims to improve service quality.
• Suppliers: Financial performance may influence procurement decisions.
• Creditors: Stable liquidity provides assurance of debt repayment.

Next Steps

• The Company is in the process of placing an additional scanner in a current location in New York and anticipates it to be completed by the fourth quarter of fiscal 2025.
• Management is seeking to promote wider market recognition of FONARs scanner products, and to increase demand for Upright scanning at the facilities HMCA owns or manages.

Key Dates

Keywords

FONAR, MRI, Financial Results, Q3 2025, Net Income, Revenues, HMCA, Scans, Operating Income, Medical Equipment